Health care expert Fred Goldstein sits down with Melissa Andel, principal and founder of CommonHealth Solutions, to discuss the long-awaited launch of Humira biosimilars and what Amgen’s pricing strategy means for patients and payers.
Unscripted – The AMCP Podcast
Tackle today's challenges, trends, and opportunities in managed care pharmacy.
Discover top managed care pharmacy news and insights.
Unscripted – The AMCP Podcast offers valuable updates for listeners and connects sponsors with health care professionals, payers, policymakers, regulators and industry leaders. Sponsors benefit from a platform that connects them with a wide network of health care professionals, payers, and industry leaders. This year, we will be sharing podcast topics on:
The presidential election and health care legislation, AI's impact on managed care pharmacy, high drug costs and cell and gene therapy, digital therapeutics and GLP-1s and community pharmacy disruption.
Interested in being a guest or know an expert? Let us know! View podcast sponsor and advertising options and view other Corporate Opportunities.
2023 will be a pivotal year for biosimilar success or failure. Health care expert Fred Goldstein sits down with Stanton Mehr of Biosimilars Review & Report, to discuss what lies in store for biosimilars and AMCP’s biosimilar initiatives this year.
Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Jennifer Graff, Senior Director of Professional Affairs at AMCP, to discuss trends to be watching regarding digital therapeutics and managed care pharmacy in 2023.
Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up!, sits down with Susan Cantrell, AMCP CEO, to discuss the significance of the recent passage of the Pre-approval Information Exchange (PIE) Act of 2022.
Andrey Ostrovsky, MD, FAAP, and Lisa Palko, PharmD, discuss the ADHD landscape, challenges, and progress, including Akili's digital therapeutics value proposition as the first FDA-authorized prescription video game treatment.
On today's episode of PopHealth Week, our guest is Eddie Martucci, PhD, co-founder & CEO of Akili Interactive, a company getting to the root of cognitive impairment by creating personalized digital therapeutics engineered to directly improve cognitive impairments.
On this episode of the AMCP Podcast Powered by PopHealth Week, co-hosts Fred Goldstein and Gregg Masters sit down with Steven G. Avey Award winner Dr. Mark McClellan and Executive Director of the AMCP Foundation, Paula J. Eichenbrenner.
On this episode of AMCP Podcast Powered by PopHealth Week, co-hosts Fred Goldstein and Gregg Masters sit down with Atul Deodhar, MD, to discuss key takeaways from 2021 The American College of Rheumatologists (ACR) Convergence conference.
On this episode of AMCP Podcast Powered by PopHealth Week, co-hosts Fred Goldstein and Gregg Masters sit down with Atul Deodhar, MD, Professor of Medicine and Medical Director of rheumatology clinics in the Division of Arthritis & Rheumatic Diseases at Oregon Health & Science University, to discuss key takeaways from 2021 The American College of Rheumatologists (ACR) Convergence conference.
Health care expert Fred Goldstein of AMCP Podcast Powered by PopHealth Week sits down with Patrick Gleason, PharmD, assistant vice president for health outcomes at Prime Therapeutics, and Nick Friedlander, PharmD, clinical programs pharmacist also in the health outcomes division at Prime Therapeutics, to discuss the digital therapeutics landscape.
Health care expert Fred Goldstein of AMCP Podcast Powered by PopHealth Week sits down with Dr. April Armstrong to discuss psoriasis, a chronic and systemic inflammatory skin disease affecting children as well as adults and the tremendous impact on their physical and mental impact on quality of life.
From the PopHealth Week Archives: In this episode from September 23, 2020, PopHealth Week engages with Jane Sarasohn-Kahn, an author, health economist, advisor, and trend-weaver supporting organizations at the intersection of health, technology, and people.
